Background This study examined whether a program for relapse prevention (PRP) is more
effective than treatment as usual (TAU) in reducing relapse and rehospitalization rates among …

Objective: This study compared the prevalence of the metabolic syndrome among outpatients
with schizophrenia and schizoaffective disorder receiving clozapine with a matched …

OBJECTIVE: Persons with severe mental illness are overrepresented in jails and prisons in
the United States. A national survey was conducted to identify assertive community treatment …

AMPA-receptor-positive modulators (Ampakines) facilitate learning and memory in animal
models and in preliminary trials in human subjects. CX516 is the first Ampakine to be studied …

Importance Long-acting injectable antipsychotics are used to reduce medication nonadherence
and relapse in schizophrenia-spectrum disorders. The relative effectiveness of long-…

Importance More effective treatments are needed for negative symptoms of schizophrenia,
which are typically chronic, disabling, and costly. Negative symptoms have previously been …

The high prevalence of adults with psychotic disorders in the criminal justice system has
received much attention recently, but our understanding of this problem is marked by diverging …

Jails and prisons have become a final destination for persons with severe mental illness in
America. Addiction, homelessness, and fragmentation of services have contributed to the …

A retrospective chart review was used to assess weight changes in 36 chronic schizophrenic
inpatients who were treated with clozapine after being treated with standard neuroleptics. …

Mental health courts have quickly proliferated in the United States and represent an attempt
to expand legal leverage and enhanced treatment access to select persons with severe …